دورية أكاديمية

[Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].

التفاصيل البيبلوغرافية
العنوان: [Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].
عنوان ترانسليتريتد: Mykoplasmen als Ursache für ambulant erworbene Pneumonien bei stationär aufgenommenen Kindern an einem Wiener Gemeindespital - Epidemiologie und Morbidität.
المؤلفون: Kurz H; Abteilung für Kinder- und Jugendheilkunde, Sozialmedizinisches Zentrum Ost - Donauspital, Wien, Austria. herbert.kurz@wienkav.at, Göpfrich H
المصدر: Wiener medizinische Wochenschrift (1946) [Wien Med Wochenschr] 2011 Apr; Vol. 161 (7-8), pp. 180-3. Date of Electronic Publication: 2010 Oct 25.
نوع المنشور: English Abstract; Journal Article
اللغة: German
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Austria NLM ID: 8708475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1563-258X (Electronic) Linking ISSN: 00435341 NLM ISO Abbreviation: Wien Med Wochenschr Subsets: MEDLINE
أسماء مطبوعة: Publication: 2003- : Wien : Springer Verlag
Original Publication: [Wien : Brüder Hollinek, 1946-
مواضيع طبية MeSH: Community-Acquired Infections/*epidemiology , Hospitalization/*statistics & numerical data , Pneumonia, Mycoplasma/*epidemiology, Administration, Oral ; Adolescent ; Anti-Bacterial Agents/administration & dosage ; Austria ; C-Reactive Protein/metabolism ; Cefuroxime/administration & dosage ; Child ; Clarithromycin/administration & dosage ; Community-Acquired Infections/drug therapy ; Cross-Sectional Studies ; Drug Therapy, Combination ; Drug Utilization/statistics & numerical data ; Female ; Hospitals, Community ; Humans ; Incidence ; Infusions, Intravenous ; Length of Stay/statistics & numerical data ; Macrolides/therapeutic use ; Male ; Pneumonia, Mycoplasma/drug therapy ; Prospective Studies
مستخلص: Background: Epidemiology and morbidity of mycoplasma-associated pneumonia in youths and children in Vienna are not known. The first objective was to elucidate the incidence and the second was to evaluate a standard antibiotic regimen with addition of a macrolid in children over 5 years.
Methods: Hospitalized patients were evaluated prospectively during 3 winter seasons. In a clinical routine setting microbiologic tests were performed, nasal secretions were tested for viruses, Chlamydia pneumoniae and Mycoplasma pneumoniae, and clinical parameters were documented.
Results: Mycoplasma pneumoniae was identified in 12 patients out of 279 (4.3%). All were 5 years and older. The mean number of days in hospital was 4.6, the number of days with fever > 38.5 degrees was 1.2, the maximal value of C-reactive protein was 48 mg/L, no complications occurred, and all children recovered completely.
Conclusion: Mycoplasma pneumoniae was identified in 4.3% of children and youths. The antibiotic regimen is appropriate as initial therapy.
References: Pathology. 1995 Apr;27(2):177-81. (PMID: 7567149)
Am Fam Physician. 2004 Sep 1;70(5):899-908. (PMID: 15368729)
Pediatr Infect Dis J. 1995 Jun;14(6):471-7. (PMID: 7667050)
Wien Klin Wochenschr. 2007;119(11-12):379-84. (PMID: 17634897)
J Clin Microbiol. 1999 Jun;37(6):1721-6. (PMID: 10325314)
BMC Microbiol. 2008 Jun 11;8:93. (PMID: 18547431)
Pediatrics. 2004 Apr;113(4):701-7. (PMID: 15060215)
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004875. (PMID: 16034954)
Wien Med Wochenschr. 1982 May 15;132(9):205-8. (PMID: 7113230)
Respir Med. 2008 Dec;102(12):1762-8. (PMID: 18703327)
Arch Dis Child. 1978 Jan;53(1):38-42. (PMID: 626517)
Lancet Infect Dis. 2001 Dec;1(5):334-44. (PMID: 11871806)
المشرفين على المادة: 0 (Anti-Bacterial Agents)
0 (Macrolides)
9007-41-4 (C-Reactive Protein)
H1250JIK0A (Clarithromycin)
O1R9FJ93ED (Cefuroxime)
تواريخ الأحداث: Date Created: 20101022 Date Completed: 20110926 Latest Revision: 20211020
رمز التحديث: 20240628
DOI: 10.1007/s10354-010-0832-z
PMID: 20963506
قاعدة البيانات: MEDLINE
الوصف
تدمد:1563-258X
DOI:10.1007/s10354-010-0832-z